Trial · NCT03463993
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With Postpartum Haemorrhage (PPH) | Up to 48 hours post-caesarean section | PPH based on Haematocrit calculation and PPH based on Haemoglobin calculation |
| Secondary | Estimated Blood Loss | At caesarean section | Blood loss during caesarean section based on visual estimation and calculation. |
| Secondary | Amount of Blood Transfused | At caesarean section up to 48 hours post-caesarean section | Requirement by participant of blood transfusion |
| Secondary | Number of Participants With Use of Additional Uterotonics | At caesarean section up to 48 hours post-caesarean section | Number of participants who received additional uterotonics such as an oxytocin infusion or prostaglandin (misoprostol). |
| Secondary | Number of Participants With Tranexamic Acid Side Effects | From intravenous infusion of the drug up to 48 hours post-caesarean section | Number of participants with adverse effects related to tranexamic acid use |
| Secondary | Number of Participants Requiring Emergency Surgery for PPH | At caesarean section up to 48 hours post-caesarean section | Number of participants requiring emergency surgical procedures to manage any PPH that occurs |
| Secondary | Number of Days of Participants' Hospital Stay | From date of randomization until the day 2 post-caesarean section (date of discharge from hospital) or date of death whichever comes earlier | The number of days the participant stayed in hospital from the date of admission to date of discharge from hospital. |
| Secondary | Neonatal Outcome - Weight | From date of delivery of neonate by caesarean section until day 2 post-caesarean section (the date of discharge from hospital) or date of death whichever comes earlier | Neonatal birth weight in grams |
| Secondary | Neonatal Outcome - APGAR Score of the Neonates at 1 Minute and 5 Minutes After Delivery | Scores at 1 minute from time of delivery and at 5 minutes after delivery | APGAR (Appearance, Pulse, Grimace, Activity, Respiration) scores out of 10 at 1 minute and 5 minutes. A measure of the physical condition of a newborn infant. It is obtained by adding points (maximum score of 2, 1, or 0 as minimum score) for Appearance (0 - blue/pale, 1 - pink body, blue extremities, 2 - pink); Pulse (0 - absent heart rate, 1 - below 100 beats per minute, 2 - over 100 beats per minute), Grimace (Reflex irritability - 0 - floppy, 1 - minimal response to stimulation, 2- prompt response to stimulation), Activity (muscle tone: 0 - absent, 1 - Flexed arms and legs, 2 - active), Respiration ( 0 - absent, 1 - slow or irregular, 2 - vigorous cry). APGAR score at 1minute or 5 minute can be a minimum of of 0 (0+0+0+0+0) or maximum of 10 (2 for each parameter above). |
| Secondary | Neonatal Outcome - Number of Neonates Admitted to the Neonatal Unit | From date of delivery of neonate by caesarean section until day 2 post-caesarean section (the date of discharge from hospital) or date of death whichever comes earlier | Number of neonates requiring admission to the neonatal unit from time of delivery at caesarean section |
| Secondary | Neonatal Outcome - Number of Neonates Diagnosed With Jaundice | From date of delivery of neonate by caesarean section until day 2 post-caesarean section (the date of discharge from hospital) or date of death whichever comes earlier | Number of neonates with clinical jaundice (yellowing of the skin or whites of the eyes) |
| Secondary | Neonatal Outcome - Thromboembolic Event | From date of delivery of neonate by caesarean section until day 2 post-caesarean section (the date of discharge from hospital) or date of death whichever comes earlier | Number of neonatal thromboembolic events |
| Secondary | Neonatal Outcome - Death | From date of delivery of neonate by caesarean section until day 2 post-caesarean section (the date of discharge from hospital) or date of death whichever comes earlier | Neonatal death that occurs |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03463993/registered